Loading...
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond
Loading...
The job search that fits your personality
Personalized matches for clinicians, for the coolest jobs in the clinic or beyond
Are you passionate about making a difference in the world of cancer genomics?
At Tempus, biological samples are processed in our in-house lab and turned into valuable genomic data. This data flows from on-site to an extensive cloud-based infrastructure and set of workflows that produce impactful insights. SaaS products are developed in-house by cross functional teams to share those insights with our clients.
Tempus’ approach to information security allows us to react to threats to any of the environments and workflows described above and identify and close gaps quickly. Our effective security operations engrained with comprehensive monitoring, testing, and risk management allow us to protect Tempus without reducing the speed at which we do business. You and your team set the security goals and design and deploy the products, controls, and workflows to ensure Tempus will continue to make a lasting impact in the field of cancer research and treatment.
As an IAM Engineer, you’ll play a critical role in fulfilling the mission ...
The Real Dill ☘️
Drug development is hard - Big Pharma wouldn't be a $1 TRILLION+ industry if it wasn't. From end to end development, some estimates show nearly a decade of work and $1B of investment is needed to bring a single drug to market, not to mention the incredible attrition rate of molecules that don't pass muster to progress from preclinical to Phase 1/2/3 clinical trials and regulatory approval. Three of the biggest challenges facing the drug development industry in increasing the success rate of bringing drugs to market are the focus of Tempus Labs: drug discovery (finding new molecules to develop), clinical trials (verifying the usage and viability of turning molecules into medicines) and diagnostics (finding the right patients to take each highly complex, specialized drug being developed). It makes sense that these processes could be opportunities for artificial intelligence to accelerate the process - helping doctors understand disease progression by finding the right patients for a trial, etc. Startups in this space are raising ludicrous amounts of money (Tempus Labs itself has raised over $1B) which is a startling contrast to the adjacent digital health space where companies are striving for overall valuations in the $1B ballpark...it's a different game, with different players, and, in some ways, even more competitive. (September 2023)
Jon Lee, PT, DPT, OCS, FAAOMPT, MBA
Pickle co-founder
Advancing precision medicine through the practical application of artificial intelligence in healthcare.
MissionFor each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data.
Wow FactorClaims >90% of the top 20 Pharma companies partner with Tempus
Pickle is not affiliated with listed companies unless otherwise noted.